Is there any difference between busulfancyclophosphamide and cyclophosphamide-busulfan in patients underwent allogeneic transplantation?

Bahçecioglu, Ömer Faruk; Gök, Selim; Durmus, Mefküre; Sarici, Ahmet

Bahçecioglu, Ömer Faruk; Gök, Selim; Durmus, Mefküre; Sarici, Ahmet.

Bahçecioglu, Ömer Faruk; University Faculty of Pharmacy. Department of Clinical Pharmacy. Malatya. TR
Gök, Selim; University Faculty of Pharmacy. Department of Clinical Pharmacy. Malatya. TR
Durmus, Mefküre; University Faculty of Pharmacy. Department of Clinical Pharmacy. Malatya. TR
Sarici, Ahmet; University Faculty of Medicine. Department of Hematology. Malatya. TR

Hematol., Transfus. Cell Ther. (Impr.) ; 43(4): 527-528, Oct.-Dec. 2021.

Article in English | LILACS | ID: biblio-1350812

Subject(s)

Humans; Transplantation, Homologous; Busulfan/therapeutic use; Cyclophosphamide/therapeutic use

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Transplantation, Homologous / Busulfan / Cyclophosphamide Limits: Humans Language: English Journal: Hematol., Transfus. Cell Ther. (Impr.) Journal subject: Hematologia / TransfusÆo de Sangue Year: 2021 Type: Article Affiliation country: Turkey Institution/Affiliation country: University Faculty of Medicine/TR / University Faculty of Pharmacy/TR

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google